Vertex Pharmaceuticals stock falls after pain drug fails in Phase 2 study
In a tumultuous turn of events for Cheetah Net Supply Chain Service (CTNT), the company’s stock has plummeted to a 52-week low, reaching a distressing price level of $1.53 USD, with InvestingPro data showing concerning financial health metrics, including negative EBITDA of -$3.66M and a market capitalization of just $5.18M. This significant drop reflects a harrowing period for the logistics firm, which has seen its market value erode by an alarming 94.56% over the past year. Investors have been grappling with a series of challenges that have beset the company, leading to a stark reassessment of its future prospects and casting a shadow over its financial health. InvestingPro analysis reveals the company maintains a high current ratio of 12.5, though it remains unprofitable over the last twelve months. The steep one-year change underscores the volatility and the intense pressures facing the supply chain sector, as CTNT struggles to navigate through a period of unprecedented disruption and competitive headwinds. Unlock 10+ additional financial insights and tips with InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.